Reference
Snast I, et al. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature. Journal of the American Academy of Dermatology 77: 88-97.e5, No. 1, Jul 2017 - Israel
Rights and permissions
About this article
Cite this article
Adalimumab/etanercept. Reactions Weekly 1664, 22 (2017). https://doi.org/10.1007/s40278-017-34302-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-34302-7